首页 > 最新文献

International Journal of Surgical Oncology最新文献

英文 中文
Factors Associated With the Presence and Severity of Nutritional Impact Symptoms in Individuals With Head and Neck Cancer Before Treatment.
IF 1.6 Q4 ONCOLOGY Pub Date : 2024-12-28 eCollection Date: 2024-01-01 DOI: 10.1155/ijso/3390646
Thainá C do Rosario, Fabíola L P Soares, Louise V O Soares, Julia S N Gallavotti, Isabela S Rodrigues, Camila B do Prado, Olívia P G de Podestá, Katia Cirlene G Viana, Ricardo M Rocha, Jeferson Lenzi, José Roberto V de Podestá, Evandro D de Souza, Fabiano K Haraguchi, Glenda B Petarli, André S Leopoldo, Luciane B Salaroli

Background: As head and neck cancer (HNC) affects regions directly related to the digestive tract, it is consistently associated with nutritional impact symptoms (NISs), which further reduce food intake and affect nutritional status. Early identification of patients with NIS can assist therapy. Method: This is a cross-sectional study with HNC patients from a cancer reference hospital. Sociodemographic, lifestyle, clinical, and anthropometric data were collected, along with information on nutritional risk screening and screening for NIS. Results: Cancer in the larynx (p=0.031) showed a 6.67 lower NIS score than that in the oral cavity. Ex-smokers (p=0.019) showed a 5.87 lower NIS score and nutritional risk (p=0.009) increased NIS scores by 6.15 points. Conclusion: Tumor location, smoking, and the presence of nutritional risk influence the quantity and severity of NIS.

{"title":"Factors Associated With the Presence and Severity of Nutritional Impact Symptoms in Individuals With Head and Neck Cancer Before Treatment.","authors":"Thainá C do Rosario, Fabíola L P Soares, Louise V O Soares, Julia S N Gallavotti, Isabela S Rodrigues, Camila B do Prado, Olívia P G de Podestá, Katia Cirlene G Viana, Ricardo M Rocha, Jeferson Lenzi, José Roberto V de Podestá, Evandro D de Souza, Fabiano K Haraguchi, Glenda B Petarli, André S Leopoldo, Luciane B Salaroli","doi":"10.1155/ijso/3390646","DOIUrl":"https://doi.org/10.1155/ijso/3390646","url":null,"abstract":"<p><p><b>Background:</b> As head and neck cancer (HNC) affects regions directly related to the digestive tract, it is consistently associated with nutritional impact symptoms (NISs), which further reduce food intake and affect nutritional status. Early identification of patients with NIS can assist therapy. <b>Method:</b> This is a cross-sectional study with HNC patients from a cancer reference hospital. Sociodemographic, lifestyle, clinical, and anthropometric data were collected, along with information on nutritional risk screening and screening for NIS. <b>Results:</b> Cancer in the larynx (<i>p</i>=0.031) showed a 6.67 lower NIS score than that in the oral cavity. Ex-smokers (<i>p</i>=0.019) showed a 5.87 lower NIS score and nutritional risk (<i>p</i>=0.009) increased NIS scores by 6.15 points. <b>Conclusion:</b> Tumor location, smoking, and the presence of nutritional risk influence the quantity and severity of NIS.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":"2024 ","pages":"3390646"},"PeriodicalIF":1.6,"publicationDate":"2024-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11699980/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142933107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Self-Expandable Metal Stent for Palliation of Dysphagia in Cancer Esophagus at a Tertiary Care Center of North-East India: A Prospective Study.
IF 1.6 Q4 ONCOLOGY Pub Date : 2024-12-24 eCollection Date: 2024-01-01 DOI: 10.1155/ijso/3331040
Rohin Kundalia, Revanth Kumar Kodali, Dibyajyoti Deka, Abhijit Talukdar, Deep Jyoti Kalita, Gaurav Das, Shivaji Sharma, Mohit Malhotra

Background and Aim: Esophageal cancer is the sixth most common cancer in India with a incidence of around 4.5%. Dysphagia is the primary manifestation of advanced esophageal cancer in 80%-90% of patients. Dysphagia is one of the most distressing and debilitating symptom for the patients. The use of self-expanding metallic stents (SEMS) has revolutionized the treatment of dysphagia in esophageal cancer patients. This study aims to assess the role of SEMS in the palliation of dysphagia in patients with esophageal cancer. Methods: This was a single-center, prospective observational study conducted in the Department of Surgical Oncology at Dr. B. Borooah Cancer Institute in Guwahati, India, from April 2019 to March 2020. Patients were assessed after stent placement for improvements in dysphagia, pain relief, nutritional status, and associated complications. Results: One week after stent placement, 65.3% of patients were able to tolerate semisolid food and 6.1% could tolerate solids. Prior to stent insertion, 87.8% had Grade 4 dysphagia, but at 6 months post-SEMS placement, 90.2% had only Grade 1 dysphagia. This represented a statistically significant improvement in the dysphagia grade, with a p value less than 0.0001. Further analysis using ANOVA and paired t-tests showed significant improvements in weight, body mass index (BMI), and serum albumin at 1, 3, and 6 months after stent placement, with p values less than 0.001. Conclusion: The results of this study demonstrated that the placement of SEMS is a safe and effective palliative intervention for management of dysphagia in carcinoma esophagus, leading to improvements in patient nutrition and quality of life, with relatively few associated complications.

{"title":"Self-Expandable Metal Stent for Palliation of Dysphagia in Cancer Esophagus at a Tertiary Care Center of North-East India: A Prospective Study.","authors":"Rohin Kundalia, Revanth Kumar Kodali, Dibyajyoti Deka, Abhijit Talukdar, Deep Jyoti Kalita, Gaurav Das, Shivaji Sharma, Mohit Malhotra","doi":"10.1155/ijso/3331040","DOIUrl":"10.1155/ijso/3331040","url":null,"abstract":"<p><p><b>Background and Aim:</b> Esophageal cancer is the sixth most common cancer in India with a incidence of around 4.5%. Dysphagia is the primary manifestation of advanced esophageal cancer in 80%-90% of patients. Dysphagia is one of the most distressing and debilitating symptom for the patients. The use of self-expanding metallic stents (SEMS) has revolutionized the treatment of dysphagia in esophageal cancer patients. This study aims to assess the role of SEMS in the palliation of dysphagia in patients with esophageal cancer. <b>Methods:</b> This was a single-center, prospective observational study conducted in the Department of Surgical Oncology at Dr. B. Borooah Cancer Institute in Guwahati, India, from April 2019 to March 2020. Patients were assessed after stent placement for improvements in dysphagia, pain relief, nutritional status, and associated complications. <b>Results:</b> One week after stent placement, 65.3% of patients were able to tolerate semisolid food and 6.1% could tolerate solids. Prior to stent insertion, 87.8% had Grade 4 dysphagia, but at 6 months post-SEMS placement, 90.2% had only Grade 1 dysphagia. This represented a statistically significant improvement in the dysphagia grade, with a p value less than 0.0001. Further analysis using ANOVA and paired t-tests showed significant improvements in weight, body mass index (BMI), and serum albumin at 1, 3, and 6 months after stent placement, with p values less than 0.001. <b>Conclusion:</b> The results of this study demonstrated that the placement of SEMS is a safe and effective palliative intervention for management of dysphagia in carcinoma esophagus, leading to improvements in patient nutrition and quality of life, with relatively few associated complications.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":"2024 ","pages":"3331040"},"PeriodicalIF":1.6,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11688132/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142915923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Retrospective 8-Year Single Institutional Study in Germany Regarding Diagnosis, Treatment, and Outcome of Malignant Parotid Tumors. 德国一项为期 8 年的单一机构恶性腮腺肿瘤诊断、治疗和预后回顾性研究。
IF 1.6 Q4 ONCOLOGY Pub Date : 2024-12-09 eCollection Date: 2024-01-01 DOI: 10.1155/ijso/7598063
S Andrianopoulou, L S Fiedler, B M Lippert, O C Bulut

This study sought to comprehensively evaluate the diagnosis, therapeutic interventions, and outcomes of individuals afflicted with malignant parotid tumors at a tertiary care otolaryngology department in Heilbronn, Germany, spanning the years 2010-2018. The primary objective was to juxtapose this dataset with findings from analogous single and multicenter investigations. We conducted a meticulous analysis of electronic medical records pertaining to 45 patients subjected to primary parotid cancer treatment. The male-to-female ratio was 3:2, with an average age of 61 years. Predominant histological types included mucoepidermoid and squamous cell carcinomas, with ultrasound emerging as the predominant diagnostic modality (97.8% sensitivity). Intraoperative frozen sections exhibited a high level of sensitivity. Notably, lymph node metastasis was prevalent in T3 tumors, frequently located intraparotid and at Neck level II. Solely one patient exhibited distant metastases (pulmonary). All patients underwent parotidectomy, and 29% necessitated a secondary procedure due to positive resection margins. Postoperative complications encompassed facial nerve palsy, seromas, and salivary fistulas. Adjuvant radiotherapy (38%) was recommended for high-grade tumors, T3/T4 stage, N+, perineural invasion (PNI), and positive or uncertain surgical margins. Neck dissection was executed in 67% of instances, with 20% revealing occult lymph node metastases. Recurrence manifested in 22% of patients, primarily as locoregional recurrence (80%) and distant metastases (20%). The 3-year recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) rates stood at 72.1%, 91.9%, and 87.5%, respectively. Noteworthy factors influencing RFS included preoperative facial palsy, T stage, resection margins, and PNI. In summary, the management of parotid cancer involving surgical interventions, neck dissection, and radiotherapy in high-risk patients yielded commendable outcomes with minimal complications, showcasing survival rates exceeding 70%. Timely diagnosis at an early stage is imperative for achieving tumor-free margins and enhancing survival rates. More assertive therapeutic strategies are advocated for cases presenting with preoperative facial nerve palsy and PNI.

本研究旨在全面评估德国海尔布隆一家三级甲等医院耳鼻喉科在 2010-2018 年间对腮腺恶性肿瘤患者的诊断、治疗干预和疗效。主要目的是将该数据集与类似的单中心和多中心研究结果进行对比。我们对45名接受原发性腮腺癌治疗的患者的电子病历进行了细致分析。男女比例为 3:2,平均年龄为 61 岁。主要组织学类型包括粘液表皮样癌和鳞状细胞癌,超声波是主要的诊断方式(灵敏度为97.8%)。术中冰冻切片的灵敏度也很高。值得注意的是,淋巴结转移主要发生在T3肿瘤,通常位于腮腺内和颈部二级。只有一名患者出现远处转移(肺部)。所有患者都接受了腮腺切除术,29%的患者因切除边缘阳性而需要进行二次手术。术后并发症包括面神经麻痹、血清瘤和唾液瘘。对于高级别肿瘤、T3/T4分期、N+、神经周围浸润(PNI)以及手术切缘阳性或不确定的患者,建议进行辅助放疗(38%)。67%的患者进行了颈部清扫,其中20%发现了隐匿性淋巴结转移。22%的患者出现复发,主要表现为局部复发(80%)和远处转移(20%)。3年无复发生存率(RFS)、癌症特异性生存率(CSS)和总生存率(OS)分别为72.1%、91.9%和87.5%。值得注意的影响RFS的因素包括术前面瘫、T期、切除边缘和PNI。总之,对高危患者进行包括手术干预、颈部切除和放疗在内的腮腺癌治疗取得了值得称道的结果,并发症极少,生存率超过 70%。早期及时诊断是实现无瘤边缘和提高生存率的关键。对于术前出现面神经麻痹和 PNI 的病例,应采取更加果断的治疗策略。
{"title":"A Retrospective 8-Year Single Institutional Study in Germany Regarding Diagnosis, Treatment, and Outcome of Malignant Parotid Tumors.","authors":"S Andrianopoulou, L S Fiedler, B M Lippert, O C Bulut","doi":"10.1155/ijso/7598063","DOIUrl":"10.1155/ijso/7598063","url":null,"abstract":"<p><p>This study sought to comprehensively evaluate the diagnosis, therapeutic interventions, and outcomes of individuals afflicted with malignant parotid tumors at a tertiary care otolaryngology department in Heilbronn, Germany, spanning the years 2010-2018. The primary objective was to juxtapose this dataset with findings from analogous single and multicenter investigations. We conducted a meticulous analysis of electronic medical records pertaining to 45 patients subjected to primary parotid cancer treatment. The male-to-female ratio was 3:2, with an average age of 61 years. Predominant histological types included mucoepidermoid and squamous cell carcinomas, with ultrasound emerging as the predominant diagnostic modality (97.8% sensitivity). Intraoperative frozen sections exhibited a high level of sensitivity. Notably, lymph node metastasis was prevalent in T3 tumors, frequently located intraparotid and at Neck level II. Solely one patient exhibited distant metastases (pulmonary). All patients underwent parotidectomy, and 29% necessitated a secondary procedure due to positive resection margins. Postoperative complications encompassed facial nerve palsy, seromas, and salivary fistulas. Adjuvant radiotherapy (38%) was recommended for high-grade tumors, T3/T4 stage, N+, perineural invasion (PNI), and positive or uncertain surgical margins. Neck dissection was executed in 67% of instances, with 20% revealing occult lymph node metastases. Recurrence manifested in 22% of patients, primarily as locoregional recurrence (80%) and distant metastases (20%). The 3-year recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS) rates stood at 72.1%, 91.9%, and 87.5%, respectively. Noteworthy factors influencing RFS included preoperative facial palsy, T stage, resection margins, and PNI. In summary, the management of parotid cancer involving surgical interventions, neck dissection, and radiotherapy in high-risk patients yielded commendable outcomes with minimal complications, showcasing survival rates exceeding 70%. Timely diagnosis at an early stage is imperative for achieving tumor-free margins and enhancing survival rates. More assertive therapeutic strategies are advocated for cases presenting with preoperative facial nerve palsy and PNI.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":"2024 ","pages":"7598063"},"PeriodicalIF":1.6,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11649345/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142839250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation and Cross-Cultural Adaptation of the Toronto Extremity Salvage Score (TESS) for Latin American Spanish-Speaking Patients With Limb Sarcoma: Latin American Spanish TESS Adaptation. 针对拉丁美洲西班牙语肢体肉瘤患者的多伦多肢体救治评分(TESS)的翻译和跨文化改编:拉丁美洲西班牙语 TESS 适应性。
IF 1.6 Q4 ONCOLOGY Pub Date : 2024-11-06 eCollection Date: 2024-01-01 DOI: 10.1155/2024/7887845
Oscar Ceballos, Jorge Cabrolier, Begoña Chehade, Francisco Hardoy, Francisco Cortes, Ricardo Tolosa, Orlando Wevar

Background and Objectives: This study aims to translate and culturally adapt the Toronto Extremity Salvage Score (TESS) for Latin American Spanish-speaking patients, enhancing the tool's accessibility for evaluating postsurgical functional outcomes in sarcoma patients across Latin America. Methods: The TESS questionnaires for lower extremity (LE) and upper extremity (UE) were translated and adapted following international guidelines. The process included forward and backward translation, expert committee review, and pretesting with cognitive interviewing. Patients treated for bone or soft tissue tumors in LE or UE were recruited to complete the adapted questionnaires. Test-retest reliability was evaluated by having participants complete the questionnaire again 2 weeks after the initial assessment. Results: A total of 89 participants completed the questionnaires. The study found high internal consistency, with Cronbach's alpha values reaching 0.9437 for LE and 0.9402 for UE. An agreement rate of 98.4% for the global score of TESS-LE (95% confidence interval [CI]: 0.909-1.059) and 93.9% for TESS-UE (95% CI: 0.882-0.995) was observed, demonstrating strong test-retest reliability. Conclusions: The Latin American Spanish version of TESS for both lower and upper extremities is a reliable and culturally appropriate tool for assessing physical function in limb sarcoma patients. Further validation across diverse Latin American populations is encouraged to strengthen its broad applicability.

背景与目标:本研究旨在翻译多伦多肢体救治评分(TESS)并对其进行文化调整,使其适用于拉丁美洲的西班牙语患者,从而提高该工具在评估拉丁美洲肉瘤患者手术后功能预后方面的可及性。方法:下肢(LE)和上肢(UE)的 TESS 问卷按照国际指南进行了翻译和改编。整个过程包括正向和反向翻译、专家委员会审核以及认知访谈预试。我们招募了接受骨肿瘤或上肢软组织肿瘤治疗的患者来完成改编后的问卷。在初次评估两周后,让参与者再次填写问卷,以评估重测可靠性。结果:共有 89 名参与者完成了问卷。研究发现,问卷的内部一致性很高,LE 的 Cronbach's alpha 值达到 0.9437,UE 的 Cronbach's alpha 值达到 0.9402。TESS-LE 的总分一致率为 98.4%(95% 置信区间[CI]:0.909-1.059),TESS-UE 的总分一致率为 93.9%(95% 置信区间[CI]:0.882-0.995),表明测试-再测可靠性很高。结论拉丁美洲西班牙语版下肢和上肢TESS是评估肢体肉瘤患者肢体功能的一种可靠且适合当地文化的工具。我们鼓励在不同的拉美人群中进一步验证该工具,以加强其广泛的适用性。
{"title":"Translation and Cross-Cultural Adaptation of the Toronto Extremity Salvage Score (TESS) for Latin American Spanish-Speaking Patients With Limb Sarcoma: Latin American Spanish TESS Adaptation.","authors":"Oscar Ceballos, Jorge Cabrolier, Begoña Chehade, Francisco Hardoy, Francisco Cortes, Ricardo Tolosa, Orlando Wevar","doi":"10.1155/2024/7887845","DOIUrl":"10.1155/2024/7887845","url":null,"abstract":"<p><p><b>Background and Objectives:</b> This study aims to translate and culturally adapt the Toronto Extremity Salvage Score (TESS) for Latin American Spanish-speaking patients, enhancing the tool's accessibility for evaluating postsurgical functional outcomes in sarcoma patients across Latin America. <b>Methods:</b> The TESS questionnaires for lower extremity (LE) and upper extremity (UE) were translated and adapted following international guidelines. The process included forward and backward translation, expert committee review, and pretesting with cognitive interviewing. Patients treated for bone or soft tissue tumors in LE or UE were recruited to complete the adapted questionnaires. Test-retest reliability was evaluated by having participants complete the questionnaire again 2 weeks after the initial assessment. <b>Results:</b> A total of 89 participants completed the questionnaires. The study found high internal consistency, with Cronbach's alpha values reaching 0.9437 for LE and 0.9402 for UE. An agreement rate of 98.4% for the global score of TESS-LE (95% confidence interval [CI]: 0.909-1.059) and 93.9% for TESS-UE (95% CI: 0.882-0.995) was observed, demonstrating strong test-retest reliability. <b>Conclusions:</b> The Latin American Spanish version of TESS for both lower and upper extremities is a reliable and culturally appropriate tool for assessing physical function in limb sarcoma patients. Further validation across diverse Latin American populations is encouraged to strengthen its broad applicability.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":"2024 ","pages":"7887845"},"PeriodicalIF":1.6,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142630074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Sublingual Gland Flap for Oral Reconstruction: Insights From a Single Institutional Experience. 用于口腔重建的舌下腺皮瓣:一家机构的经验启示。
IF 1.6 Q4 ONCOLOGY Pub Date : 2024-10-16 eCollection Date: 2024-01-01 DOI: 10.1155/2024/7386967
Agata Wieczorkiewicz, Joanna Kuczera, Andrei Hramyka, Krzysztof Śliwiński, Jakub Bargiel, Grażyna Wyszyńska-Pawelec, Michał Gontarz

Background: Following ablative surgery, the reconstruction of oral cavity defects is essential to ensure optimal function and aesthetically acceptable outcomes. The purpose of this study was to retrospectively analyze the effectiveness and complication rates of the sublingual gland flap (SGF) in oral soft tissue reconstruction. The procedure for harvesting SGF and the strengths and limitations of the flap are discussed. Materials and Methods: The study group consisted of 13 patients suffering from oncological diseases who underwent soft tissue reconstruction with SGF. The patient's medical charts were evaluated based on histopathological aspects, postoperative complications, and outcomes. Reconstruction of the floor of the mouth was performed in 8 patients (61.5%) and lower gingiva in 5 patients (38.5%), respectively. Results: Complete epithelialization with closure of the defect was achieved within an average of 2 weeks. The observation period ranged from 1 to 33 months, with an average duration of 11.5 months. Partial flap necrosis and ranula occurred in one patient (7.7%). Furthermore, postoperative bleeding was observed in one patient (7.7%), and wound dehiscence and abscess formation were noted in another (7.7%). Locoregional recurrence of the cancer was observed in one case (7.7%). Conclusions: The SGF is effective for achieving successful reconstruction of small- and medium-sized defects in the lower gingiva and floor of the mouth. The complication rate is relatively low.

背景:消融手术后,口腔缺损的重建对于确保最佳功能和美观效果至关重要。本研究旨在回顾性分析舌下腺皮瓣(SGF)在口腔软组织重建中的有效性和并发症发生率。本研究讨论了舌下腺皮瓣的采集过程以及该皮瓣的优势和局限性。材料和方法:研究组包括 13 名接受 SGF 软组织重建术的肿瘤患者。根据组织病理学方面、术后并发症和疗效对患者的病历进行了评估。8名患者(61.5%)进行了口底重建,5名患者(38.5%)进行了下牙龈重建。手术结果平均 2 周内缺损上皮完全闭合。观察期从 1 个月到 33 个月不等,平均为 11.5 个月。一名患者(7.7%)出现皮瓣部分坏死和溃疡。此外,一名患者(7.7%)出现术后出血,另一名患者(7.7%)出现伤口开裂和脓肿形成。有一名患者(7.7%)观察到癌症局部复发。结论SGF可成功重建下牙龈和口底的中小型缺损。并发症发生率相对较低。
{"title":"The Sublingual Gland Flap for Oral Reconstruction: Insights From a Single Institutional Experience.","authors":"Agata Wieczorkiewicz, Joanna Kuczera, Andrei Hramyka, Krzysztof Śliwiński, Jakub Bargiel, Grażyna Wyszyńska-Pawelec, Michał Gontarz","doi":"10.1155/2024/7386967","DOIUrl":"https://doi.org/10.1155/2024/7386967","url":null,"abstract":"<p><p><b>Background:</b> Following ablative surgery, the reconstruction of oral cavity defects is essential to ensure optimal function and aesthetically acceptable outcomes. The purpose of this study was to retrospectively analyze the effectiveness and complication rates of the sublingual gland flap (SGF) in oral soft tissue reconstruction. The procedure for harvesting SGF and the strengths and limitations of the flap are discussed. <b>Materials and Methods:</b> The study group consisted of 13 patients suffering from oncological diseases who underwent soft tissue reconstruction with SGF. The patient's medical charts were evaluated based on histopathological aspects, postoperative complications, and outcomes. Reconstruction of the floor of the mouth was performed in 8 patients (61.5%) and lower gingiva in 5 patients (38.5%), respectively. <b>Results:</b> Complete epithelialization with closure of the defect was achieved within an average of 2 weeks. The observation period ranged from 1 to 33 months, with an average duration of 11.5 months. Partial flap necrosis and ranula occurred in one patient (7.7%). Furthermore, postoperative bleeding was observed in one patient (7.7%), and wound dehiscence and abscess formation were noted in another (7.7%). Locoregional recurrence of the cancer was observed in one case (7.7%). <b>Conclusions:</b> The SGF is effective for achieving successful reconstruction of small- and medium-sized defects in the lower gingiva and floor of the mouth. The complication rate is relatively low.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":"2024 ","pages":"7386967"},"PeriodicalIF":1.6,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11498975/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142510151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Index Combining Pan-Immune-Inflammatory Index and Hemoglobin Levels (PIV/Hb) Predicts Trismus Rates Efficiently after Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer. 结合泛免疫炎症指数和血红蛋白水平(PIV/Hb)的新指数能有效预测局部晚期鼻咽癌化疗后的三联征发生率
IF 1.6 Q4 ONCOLOGY Pub Date : 2024-09-30 eCollection Date: 2024-01-01 DOI: 10.1155/2024/2124006
Efsun Somay, Busra Yilmaz, Erkan Topkan, Beyza Sirin Ozdemir, Duriye Ozturk, Ali Ayberk Besen, Huseyin Mertsoylu, Ugur Selek

Purpose: To evaluate the predictive potency of a novel index combining the pan-immune-inflammatory index and hemoglobin levels (PIV/Hb) for the prevalence of radiation-induced trismus (RIT) in patients with locally advanced nasopharyngeal cancer (LA-NPC) receiving concurrent chemoradiotherapy (CCRT).

Methods: Data from 228 LA-NPC patients were retrospectively examined. Maximum mouth openings (MMO) were measured to confirm the presence of RIT, defined as MMOs ≤35 mm. Complete blood test results from the first day of CCRT were used to calculate PIV/Hb levels. A potential relationship between pretreatment PIV/Hb and the RIT status was evaluated using receiver operating characteristic (ROC) curve analysis.

Results: Post-CCRT RIT was diagnosed in 20.2% of the patients. The ROC curve analysis determined 68.4 g/dL as the ideal PIV/Hb cutoff that effectively divided patients into two distinct groups (area under the curve: 94.7%; specificity: 86.4%; sensitivity: 87.4%). RIT was significantly more prevalent in the PIV/Hb > 68 group than in the PIV/Hb < 68 group (58.8% vs. 3.8%; P < 0.001). Multivariate logistic regression analysis showed that a pre-CCRT PIV > 68 was independently associated with significantly higher rates of RIT.

Conclusion: Higher pretreatment levels of the novel PIV/Hb index predict increased RIT rates following definitive CCRT for LA-NPCs.

目的:评估结合泛免疫炎症指数和血红蛋白水平(PIV/Hb)的新型指数对同时接受化学放疗(CCRT)的局部晚期鼻咽癌(LA-NPC)患者放射诱发三联征(RIT)发生率的预测效力:方法: 对 228 名 LA-NPC 患者的数据进行了回顾性研究。测量最大张口度(MMO)以确认是否存在 RIT,MMO ≤35 mm 即为 RIT。CCRT 第一天的全血检验结果用于计算 PIV/Hb 水平。使用接收器操作特征(ROC)曲线分析评估了治疗前 PIV/Hb 与 RIT 状态之间的潜在关系:结果:20.2%的患者被诊断为CCRT后RIT。ROC 曲线分析确定 68.4 g/dL 为理想的 PIV/Hb 临界值,可有效地将患者分为两组(曲线下面积:94.7%;特异性:86.4%;灵敏度:87.4%)。PIV/Hb > 68 组的 RIT 发生率明显高于 PIV/Hb P < 0.001 组)。多变量逻辑回归分析显示,CCRT前PIV>68与RIT发生率明显较高独立相关:结论:新型 PIV/Hb 指数的预处理水平越高,预示着 LA-NPCs 确诊 CCRT 后的 RIT 率越高。
{"title":"Novel Index Combining Pan-Immune-Inflammatory Index and Hemoglobin Levels (PIV/Hb) Predicts Trismus Rates Efficiently after Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer.","authors":"Efsun Somay, Busra Yilmaz, Erkan Topkan, Beyza Sirin Ozdemir, Duriye Ozturk, Ali Ayberk Besen, Huseyin Mertsoylu, Ugur Selek","doi":"10.1155/2024/2124006","DOIUrl":"https://doi.org/10.1155/2024/2124006","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the predictive potency of a novel index combining the pan-immune-inflammatory index and hemoglobin levels (PIV/Hb) for the prevalence of radiation-induced trismus (RIT) in patients with locally advanced nasopharyngeal cancer (LA-NPC) receiving concurrent chemoradiotherapy (CCRT).</p><p><strong>Methods: </strong>Data from 228 LA-NPC patients were retrospectively examined. Maximum mouth openings (MMO) were measured to confirm the presence of RIT, defined as MMOs ≤35 mm. Complete blood test results from the first day of CCRT were used to calculate PIV/Hb levels. A potential relationship between pretreatment PIV/Hb and the RIT status was evaluated using receiver operating characteristic (ROC) curve analysis.</p><p><strong>Results: </strong>Post-CCRT RIT was diagnosed in 20.2% of the patients. The ROC curve analysis determined 68.4 g/dL as the ideal PIV/Hb cutoff that effectively divided patients into two distinct groups (area under the curve: 94.7%; specificity: 86.4%; sensitivity: 87.4%). RIT was significantly more prevalent in the PIV/Hb > 68 group than in the PIV/Hb < 68 group (58.8% vs. 3.8%; <i>P</i> < 0.001). Multivariate logistic regression analysis showed that a pre-CCRT PIV > 68 was independently associated with significantly higher rates of RIT.</p><p><strong>Conclusion: </strong>Higher pretreatment levels of the novel PIV/Hb index predict increased RIT rates following definitive CCRT for LA-NPCs.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":"2024 ","pages":"2124006"},"PeriodicalIF":1.6,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458266/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Early Postoperative Morbidity and Mortality following Extremity Metastatic Pathologic or Impending Fracture Fixation. 四肢转移性病理性骨折或即将发生的骨折固定术后早期发病率和死亡率的风险因素。
IF 1.6 Q4 ONCOLOGY Pub Date : 2024-09-12 eCollection Date: 2024-01-01 DOI: 10.1155/2024/3565134
Patrick Qi Wang, Brynn P Charron, Kalter Hali, Matthew Raleigh, Christopher Del Balso, Mark D Macleod, David W Sanders, Abdel-Rahman Lawendy

Background: As cancer survivorship continues to improve, the perioperative morbidity and mortality following surgical treatment of metastatic bone disease become an increasingly important consideration. The objective of this study is to identify risk factors for early postoperative complications and mortality following extremity prophylactic fixation and pathologic fracture stabilization.

Methods: A single-centre retrospective review of 185 patients (226 total surgeries) who underwent prophylactic fixation or pathologic fracture stabilization for extremity metastatic bone disease between 2005 and 2020 was performed. Skull, spine, pelvic, and revision surgeries along with diagnosis of primary bone neoplasm were excluded. Univariate, multivariate, and subgroup analyses were performed to identify predictors and independent risk factors for 30-day postoperative morbidity and mortality.

Results: Primary cancers included lung (n = 41), breast (n = 36), multiple myeloma (n = 35), prostate (n = 16), lymphoma (n = 11), renal cell carcinoma (n = 10), and other (n = 36). The 30-day postoperative complication and mortality rates were 32.30% (n = 73) and 17.26% (n = 39), respectively. The most common complications were pulmonary-related, cardiac events, surgical site infection, sepsis, and thromboembolism. Pathologic fracture, presence of extra-skeletal metastases, longer surgical duration, and blood transfusion requirements were associated with 30-day postoperative complications overall. A past medical history for cardiac disease was also associated with systemic but not local surgical complications. Pathologic fracture, presence of extra-skeletal metastases, lung cancer, blood transfusion requirements, and increasing pack-year smoking history were predictors for 30-day mortality. In the multivariate analysis, pathologic fracture (p=0.016) and presence of extra-skeletal metastases (p=0.029) were independent predictors of complications. For mortality, pathologic fracture (p=0.014), presence of extra-skeletal metastases (p=0.0085), and increased blood transfusion requirements (p=0.048) were independent risk factors.

Conclusions: The findings of this study provide additional guidance for perioperative risk assessment and patient counselling. Additionally, improving clinical assessment tools to identify and quantify patients at risk of pathologic fractures becomes increasingly important given the significant morbidity and mortality associated with pathologic fracture treatment.

背景:随着癌症生存率的不断提高,转移性骨病手术治疗后的围手术期发病率和死亡率成为越来越重要的考虑因素。本研究旨在确定四肢预防性固定和病理性骨折稳定术后早期并发症和死亡率的风险因素:对 2005 年至 2020 年期间因四肢转移性骨病接受预防性固定或病理性骨折稳定术的 185 例患者(共 226 例手术)进行了单中心回顾性研究。颅骨、脊柱、骨盆和翻修手术以及原发性骨肿瘤诊断均被排除在外。进行了单变量、多变量和亚组分析,以确定术后30天发病率和死亡率的预测因素和独立风险因素:原发性癌症包括肺癌(41 例)、乳腺癌(36 例)、多发性骨髓瘤(35 例)、前列腺癌(16 例)、淋巴瘤(11 例)、肾细胞癌(10 例)和其他癌症(36 例)。术后 30 天的并发症和死亡率分别为 32.30%(73 例)和 17.26%(39 例)。最常见的并发症是肺部相关并发症、心脏事件、手术部位感染、败血症和血栓栓塞。病理性骨折、存在骨骼外转移瘤、手术时间较长以及需要输血与术后30天的总体并发症有关。既往心脏病史也与全身性手术并发症有关,但与局部手术并发症无关。病理性骨折、存在骨骼外转移瘤、肺癌、需要输血以及吸烟年数增加是30天死亡率的预测因素。在多变量分析中,病理性骨折(p=0.016)和骨骼外转移(p=0.029)是并发症的独立预测因素。就死亡率而言,病理性骨折(p=0.014)、存在骨骼外转移瘤(p=0.0085)和输血需求增加(p=0.048)是独立的风险因素:本研究结果为围术期风险评估和患者咨询提供了更多指导。此外,鉴于病理性骨折治疗带来的巨大发病率和死亡率,改进临床评估工具以识别和量化有病理性骨折风险的患者变得越来越重要。
{"title":"Risk Factors for Early Postoperative Morbidity and Mortality following Extremity Metastatic Pathologic or Impending Fracture Fixation.","authors":"Patrick Qi Wang, Brynn P Charron, Kalter Hali, Matthew Raleigh, Christopher Del Balso, Mark D Macleod, David W Sanders, Abdel-Rahman Lawendy","doi":"10.1155/2024/3565134","DOIUrl":"https://doi.org/10.1155/2024/3565134","url":null,"abstract":"<p><strong>Background: </strong>As cancer survivorship continues to improve, the perioperative morbidity and mortality following surgical treatment of metastatic bone disease become an increasingly important consideration. The objective of this study is to identify risk factors for early postoperative complications and mortality following extremity prophylactic fixation and pathologic fracture stabilization.</p><p><strong>Methods: </strong>A single-centre retrospective review of 185 patients (226 total surgeries) who underwent prophylactic fixation or pathologic fracture stabilization for extremity metastatic bone disease between 2005 and 2020 was performed. Skull, spine, pelvic, and revision surgeries along with diagnosis of primary bone neoplasm were excluded. Univariate, multivariate, and subgroup analyses were performed to identify predictors and independent risk factors for 30-day postoperative morbidity and mortality.</p><p><strong>Results: </strong>Primary cancers included lung (<i>n</i> = 41), breast (<i>n</i> = 36), multiple myeloma (<i>n</i> = 35), prostate (<i>n</i> = 16), lymphoma (<i>n</i> = 11), renal cell carcinoma (<i>n</i> = 10), and <i>other</i> (<i>n</i> = 36). The 30-day postoperative complication and mortality rates were 32.30% (<i>n</i> = 73) and 17.26% (<i>n</i> = 39), respectively. The most common complications were pulmonary-related, cardiac events, surgical site infection, sepsis, and thromboembolism. Pathologic fracture, presence of extra-skeletal metastases, longer surgical duration, and blood transfusion requirements were associated with 30-day postoperative complications overall. A past medical history for cardiac disease was also associated with systemic but not local surgical complications. Pathologic fracture, presence of extra-skeletal metastases, lung cancer, blood transfusion requirements, and increasing pack-year smoking history were predictors for 30-day mortality. In the multivariate analysis, pathologic fracture (<i>p</i>=0.016) and presence of extra-skeletal metastases (<i>p</i>=0.029) were independent predictors of complications. For mortality, pathologic fracture (<i>p</i>=0.014), presence of extra-skeletal metastases (<i>p</i>=0.0085), and increased blood transfusion requirements (<i>p</i>=0.048) were independent risk factors.</p><p><strong>Conclusions: </strong>The findings of this study provide additional guidance for perioperative risk assessment and patient counselling. Additionally, improving clinical assessment tools to identify and quantify patients at risk of pathologic fractures becomes increasingly important given the significant morbidity and mortality associated with pathologic fracture treatment.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":"2024 ","pages":"3565134"},"PeriodicalIF":1.6,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11412750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142298247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differentiated Thyroid Carcinoma Long-Term Prognostic Factors. 分化型甲状腺癌的长期预后因素
IF 1.6 Q4 ONCOLOGY Pub Date : 2024-09-10 eCollection Date: 2024-01-01 DOI: 10.1155/2024/1067447
Pacheco-Ojeda Luis, Martínez-Jaramillo Ana Lucía, Romo-Castillo Hugo, Recalde-Maldonado Ramiro, Cañizares-Quisiguiña Stalin

Introduction: Thyroid cancer is the most common cancer in women in Ecuador.

Objective: The aim of this study was to determine the demographics and clinical and treatment variables of patients with papillary or follicular thyroid cancer, referred to as differentiated thyroid cancer (DTC), treated at a third-level hospital in Quito, Ecuador.

Methods: We reviewed retrospectively the medical records of patients with DTC, who underwent surgical treatment, from 1990 to 2019. Data included demographics, pathological information, clinical stage, type of surgery, and radioactive iodine (RAI) adjuvant therapy. Patients were monitored for up to 29 years (median follow-up time 6.9 years).

Results: The corrected overall 5-, 10-, 20-, and 30-year survival rates (Kaplan-Meier) were 93%, 85%, 70%, and 63%, respectively. On univariate analysis, age, histological type, tumor grade, histological variants, capsular invasion, vascular invasion, tumor size, clinical stage, distant metastases at diagnosis, surgical margins, extrathyroidal invasion, radioactive iodine adjuvant treatment, and locoregional recurrence were found to be significant prognostic factors. In a multivariate analysis, the following independent variables: age over 55 years, extrathyroidal spread, metastasis at diagnosis, and stage II to IV raised the risk of death (hazard risk) (HR).

Conclusions: Age over 55 years, extrathyroidal spread, metastasis at diagnosis, and advanced clinical stage were found to have a harmful prognosis and an increased risk of death in a series of Ecuadorian patients surgically treated for a DTC.

简介:甲状腺癌是厄瓜多尔妇女最常见的癌症:甲状腺癌是厄瓜多尔妇女最常见的癌症:本研究旨在确定在厄瓜多尔基多一家三级医院接受治疗的甲状腺乳头状癌或滤泡状癌(简称分化型甲状腺癌(DTC))患者的人口统计学特征、临床和治疗变量:我们回顾性地查阅了1990年至2019年接受手术治疗的DTC患者的病历。数据包括人口统计学、病理学信息、临床分期、手术类型和放射性碘(RAI)辅助治疗。对患者进行了长达29年的监测(中位随访时间为6.9年):经校正的5年、10年、20年和30年总生存率(Kaplan-Meier)分别为93%、85%、70%和63%。单变量分析发现,年龄、组织学类型、肿瘤分级、组织学变异、囊腔侵犯、血管侵犯、肿瘤大小、临床分期、诊断时远处转移、手术切缘、甲状腺外侵犯、放射性碘辅助治疗和局部复发是重要的预后因素。在多变量分析中,以下自变量提高了死亡风险(危险风险):55岁以上、甲状腺外扩散、诊断时的转移以及II期至IV期:结论:在一系列接受DTC手术治疗的厄瓜多尔患者中,年龄超过55岁、甲状腺外转移、确诊时有转移以及临床分期较晚都会对预后不利并增加死亡风险。
{"title":"Differentiated Thyroid Carcinoma Long-Term Prognostic Factors.","authors":"Pacheco-Ojeda Luis, Martínez-Jaramillo Ana Lucía, Romo-Castillo Hugo, Recalde-Maldonado Ramiro, Cañizares-Quisiguiña Stalin","doi":"10.1155/2024/1067447","DOIUrl":"https://doi.org/10.1155/2024/1067447","url":null,"abstract":"<p><strong>Introduction: </strong>Thyroid cancer is the most common cancer in women in Ecuador.</p><p><strong>Objective: </strong>The aim of this study was to determine the demographics and clinical and treatment variables of patients with papillary or follicular thyroid cancer, referred to as differentiated thyroid cancer (DTC), treated at a third-level hospital in Quito, Ecuador.</p><p><strong>Methods: </strong>We reviewed retrospectively the medical records of patients with DTC, who underwent surgical treatment, from 1990 to 2019. Data included demographics, pathological information, clinical stage, type of surgery, and radioactive iodine (RAI) adjuvant therapy. Patients were monitored for up to 29 years (median follow-up time 6.9 years).</p><p><strong>Results: </strong>The corrected overall 5-, 10-, 20-, and 30-year survival rates (Kaplan-Meier) were 93%, 85%, 70%, and 63%, respectively. On univariate analysis, age, histological type, tumor grade, histological variants, capsular invasion, vascular invasion, tumor size, clinical stage, distant metastases at diagnosis, surgical margins, extrathyroidal invasion, radioactive iodine adjuvant treatment, and locoregional recurrence were found to be significant prognostic factors. In a multivariate analysis, the following independent variables: age over 55 years, extrathyroidal spread, metastasis at diagnosis, and stage II to IV raised the risk of death (hazard risk) (HR).</p><p><strong>Conclusions: </strong>Age over 55 years, extrathyroidal spread, metastasis at diagnosis, and advanced clinical stage were found to have a harmful prognosis and an increased risk of death in a series of Ecuadorian patients surgically treated for a DTC.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":"2024 ","pages":"1067447"},"PeriodicalIF":1.6,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11407879/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142298246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors of Oral Squamous Cell Carcinoma with Special Emphasis on Areca Nut Usage and Its Association with Clinicopathological Parameters and Recurrence. 口腔鳞状细胞癌的风险因素,特别强调阿月浑子的使用及其与临床病理参数和复发的关系。
IF 1.6 Q4 ONCOLOGY Pub Date : 2024-08-28 eCollection Date: 2024-01-01 DOI: 10.1155/2024/9725822
Atif Ali Hashmi, Ghazala Mudassir, Khushbakht Rashid, Umair Arshad Malik, Shamail Zia, Fazail Zia, Muhammad Irfan

Introduction: Oral squamous cell carcinoma (OSCC) is the most prevalent type of head and neck cancer and is associated with high mortality, particularly in Southeast Asian countries. Areca nut usage, smoking, and alcohol consumption are the most common risk factors for OSCC. Areca nut chewing is highly prevalent in Pakistan and has been attributed to an increase in OSCC cases. This study aimed to determine the association between areca nut usage and various clinicopathological features of OSCC and further evaluate the association of clinicopathological parameters of OSCC with tumor recurrence.

Materials and methods: The study was conducted using the data of 228 patients with OSCC resected at Liaquat National Hospital, Karachi, Pakistan, over 5 years between 2018 and 2022. Clinicopathological data were collected from hospital archives, and associations between various risk factors and clinicopathological parameters were determined.

Results: Males were more commonly affected (77.2%), and the most common age group was <50 years (54.4%). Areca nut usage was reported in 59.6% of cases, and the buccal mucosa was the most common site (62.7%). Areca nut usage was significantly associated with male gender, greater tumor size, greater depth of invasion (DOI), higher tumor stage, nodal stage, presence of perineural invasion (PNI), and recurrence. In addition, multivariate analysis revealed that OSCC recurrence was significantly associated with older age, larger tumor size and DOI, nodal metastasis, and areca nut usage.

Conclusion: Areca nut-related OSCCs were associated with poor prognosis and recurrence in our study population. Furthermore, OSCC recurrence was associated with various clinicopathological parameters, such as larger tumor size, a higher DOI, and nodal metastasis.

简介口腔鳞状细胞癌(OSCC)是头颈部癌症中最常见的一种,死亡率很高,尤其是在东南亚国家。咀嚼阿月浑子、吸烟和饮酒是口腔鳞状细胞癌最常见的风险因素。咀嚼阿月浑子在巴基斯坦非常普遍,也是导致 OSCC 病例增加的原因之一。本研究旨在确定咀嚼槟榔与 OSCC 的各种临床病理特征之间的关系,并进一步评估 OSCC 的临床病理参数与肿瘤复发之间的关系:该研究使用了2018年至2022年5年间在巴基斯坦卡拉奇利亚卡特国立医院切除的228例OSCC患者的数据。从医院档案中收集了临床病理数据,并确定了各种风险因素与临床病理参数之间的关联:男性患者较多(77.2%),最常见的年龄组是结论组:在我们的研究人群中,与亚麻仁相关的 OSCC 与预后不良和复发有关。此外,OSCC复发与各种临床病理参数有关,如肿瘤体积较大、DOI较高和结节转移。
{"title":"Risk Factors of Oral Squamous Cell Carcinoma with Special Emphasis on Areca Nut Usage and Its Association with Clinicopathological Parameters and Recurrence.","authors":"Atif Ali Hashmi, Ghazala Mudassir, Khushbakht Rashid, Umair Arshad Malik, Shamail Zia, Fazail Zia, Muhammad Irfan","doi":"10.1155/2024/9725822","DOIUrl":"10.1155/2024/9725822","url":null,"abstract":"<p><strong>Introduction: </strong>Oral squamous cell carcinoma (OSCC) is the most prevalent type of head and neck cancer and is associated with high mortality, particularly in Southeast Asian countries. Areca nut usage, smoking, and alcohol consumption are the most common risk factors for OSCC. Areca nut chewing is highly prevalent in Pakistan and has been attributed to an increase in OSCC cases. This study aimed to determine the association between areca nut usage and various clinicopathological features of OSCC and further evaluate the association of clinicopathological parameters of OSCC with tumor recurrence.</p><p><strong>Materials and methods: </strong>The study was conducted using the data of 228 patients with OSCC resected at Liaquat National Hospital, Karachi, Pakistan, over 5 years between 2018 and 2022. Clinicopathological data were collected from hospital archives, and associations between various risk factors and clinicopathological parameters were determined.</p><p><strong>Results: </strong>Males were more commonly affected (77.2%), and the most common age group was <50 years (54.4%). Areca nut usage was reported in 59.6% of cases, and the buccal mucosa was the most common site (62.7%). Areca nut usage was significantly associated with male gender, greater tumor size, greater depth of invasion (DOI), higher tumor stage, nodal stage, presence of perineural invasion (PNI), and recurrence. In addition, multivariate analysis revealed that OSCC recurrence was significantly associated with older age, larger tumor size and DOI, nodal metastasis, and areca nut usage.</p><p><strong>Conclusion: </strong>Areca nut-related OSCCs were associated with poor prognosis and recurrence in our study population. Furthermore, OSCC recurrence was associated with various clinicopathological parameters, such as larger tumor size, a higher DOI, and nodal metastasis.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":"2024 ","pages":"9725822"},"PeriodicalIF":1.6,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11374421/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-Effectiveness of Routine Histopathological Analysis of Doughnuts after Colorectal Surgery Three-Year Single-Centre Experience. 结肠直肠手术后甜甜圈常规组织病理学分析的成本效益 三年单中心经验
IF 1.6 Q4 ONCOLOGY Pub Date : 2024-08-19 eCollection Date: 2024-01-01 DOI: 10.1155/2024/9837336
Masood Ur Rehman, Reem Moussa, Cindy Siaw Lin, Naeem Ahmed, Abdul Rehman, Kamran Malik, Jamil Ahmed

Aim: This study aimed to assess the impact of routine histological examination of stapled colorectal anastomotic doughnuts in patients undergoing rectal cancer surgery (RCS). Justification of biopsy examination could form part of the strategies of NHS net zero practice with effort to reduce wastage and carbon footprint.

Method: A data analysis of all patients undergoing RCS during 2019-2021 at our institute was performed. We also analysed the cost of preparing and reviewing histology slides.

Results: 52 patients underwent anterior resection during the aforementioned period. Doughnuts were sent in 37 (71%) patients. 23 (62%) patients were male, and 14 (38%) were female. The median age at diagnosis was 68 (range 54-84) years. All resected specimens were adenocarcinomas. Of the 37 patients, 18 (49%) underwent low anterior resection and 19 (51%) underwent high anterior resection. Proximal doughnuts were sent in 26 (70%) patients, whereas distal doughnuts were sent in all cases. Mean distal microscopic resection margin from tumour was 22 mm (range 6-45 mm). Each doughnut required 3 slides, each costing £50 and requiring 82 minutes to fix and read. This incurred a cost of £13,650 and required 19,656 hours of preparation time. All of the doughnuts as well as resection margins were negative for malignancy.

Conclusion: Routine histopathological examination of doughnuts is time and cost-intensive however provides little or no clinical value (particularly analysis of the proximal doughnut). Distal doughnuts should only be sent for histological examination in exceptional circumstances.

目的:本研究旨在评估对接受直肠癌手术(RCS)的患者进行常规结直肠吻合口活检组织学检查的影响。活检检查的合理性可成为英国国家医疗服务体系(NHS)净零实践战略的一部分,努力减少浪费和碳足迹:方法:我们对本研究所 2019-2021 年期间接受直肠癌手术的所有患者进行了数据分析。我们还分析了准备和审查组织学切片的成本:结果:52 名患者在上述期间接受了前部切除术。37例(71%)患者送去了甜甜圈。23例(62%)患者为男性,14例(38%)为女性。确诊时的中位年龄为 68 岁(54-84 岁)。所有切除标本均为腺癌。在37名患者中,18人(49%)接受了低位前切除术,19人(51%)接受了高位前切除术。26例(70%)患者接受了近端切除,而所有病例都接受了远端切除。肿瘤远端显微切除边缘平均为 22 毫米(范围为 6-45 毫米)。每个甜甜圈需要 3 张切片,每张 50 英镑,固定和读片需要 82 分钟。这需要 13,650 英镑的成本和 19,656 小时的准备时间。所有切片以及切除边缘的恶性肿瘤均为阴性:甜甜圈的常规组织病理学检查需要大量时间和成本,但几乎没有临床价值(尤其是对近端甜甜圈的分析)。只有在特殊情况下,才应将远端甜甜圈送去进行组织病理学检查。
{"title":"Cost-Effectiveness of Routine Histopathological Analysis of Doughnuts after Colorectal Surgery Three-Year Single-Centre Experience.","authors":"Masood Ur Rehman, Reem Moussa, Cindy Siaw Lin, Naeem Ahmed, Abdul Rehman, Kamran Malik, Jamil Ahmed","doi":"10.1155/2024/9837336","DOIUrl":"10.1155/2024/9837336","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to assess the impact of routine histological examination of stapled colorectal anastomotic doughnuts in patients undergoing rectal cancer surgery (RCS). Justification of biopsy examination could form part of the strategies of NHS net zero practice with effort to reduce wastage and carbon footprint.</p><p><strong>Method: </strong>A data analysis of all patients undergoing RCS during 2019-2021 at our institute was performed. We also analysed the cost of preparing and reviewing histology slides.</p><p><strong>Results: </strong>52 patients underwent anterior resection during the aforementioned period. Doughnuts were sent in 37 (71%) patients. 23 (62%) patients were male, and 14 (38%) were female. The median age at diagnosis was 68 (range 54-84) years. All resected specimens were adenocarcinomas. Of the 37 patients, 18 (49%) underwent low anterior resection and 19 (51%) underwent high anterior resection. Proximal doughnuts were sent in 26 (70%) patients, whereas distal doughnuts were sent in all cases. Mean distal microscopic resection margin from tumour was 22 mm (range 6-45 mm). Each doughnut required 3 slides, each costing £50 and requiring 82 minutes to fix and read. This incurred a cost of £13,650 and required 19,656 hours of preparation time. All of the doughnuts as well as resection margins were negative for malignancy.</p><p><strong>Conclusion: </strong>Routine histopathological examination of doughnuts is time and cost-intensive however provides little or no clinical value (particularly analysis of the proximal doughnut). Distal doughnuts should only be sent for histological examination in exceptional circumstances.</p>","PeriodicalId":45960,"journal":{"name":"International Journal of Surgical Oncology","volume":"2024 ","pages":"9837336"},"PeriodicalIF":1.6,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Surgical Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1